The HE4 Sensitivity for Ovarian Cancer Test
Sample (blood) taken at home through finger pricking. Our Ovarian Cancer Sensitivity & Tumour Marker Test detects a biomarker for HE4. It greatly helps in detection and diagnosis by an oncologist after an HPV Test check-up. HPV is the primary cause of ovarian disease.
HE4 is a protein located in the epithelial cells of the epididymis and influences fertility. It is found in smaller amounts in the normal epithelium of reproductive tract and ovary.
It is found in large amounts of patients with OC, therefore enabling use as a tumour marker. OC is a significant health problem and has a high mortality rate.
This exam detects a biomarker indicating the levels of:
HE4 Blood Test Home Kit Instructions
HE4 sample should be taken in the morning and before taking medication. Please refrain from taking biotin supplements for 2 days before the day of sample collection.
For the the best samples, we suggest:
- Staying hydrated before taking a sample.
- Taking a warm shower to improve blood flow.
- Doing light exercise.
- Shaking the test tube gently instead of violently.
- Avoiding a hard squeeze on the finger.
- Not leaving the sample to sit for more than a day to prevent clotting.
Why should you check your HE4 with our product?
- Direct laboratory prices and support.
- Fast results and prescriptions.
- HPV Variant Tracking Option
- CE-certified sensitive PCR laboratory equipment for accurate tests.
- Pre-paid Royal Mail delivery.
- WhatsApp support during business hours.
How does the Ovarian Cancer Test work?
To analyze and receive results:
- Access the link provided in the written instructions on the test kit.
- Collect samples according to instructions.
- Put the collected sample into the provided additional box.
- Locate the nearest drop box through the Royal Mail app.
- Place the box into the drop box to be delivered and analyzed.
- Receive your results in 1-3 days.
Order your Ovarian test kit and collect your sample at home.
Drop off the sample in the Royal Mail Red Street Box. Use the Track 24/48 return label to the laboratory.
Receive your results through email or by opening your dashboard on our site.
HE4 Blood Sample Management
Finally, when preparing your HE4 sample, please ensure that it is not left unattended for 1-7 days. Submit the sample to the laboratory on the same day it is collected or within a few hours thereafter.
Schedule your dropbox delivery prior to the designated final delivery time on that day. Ensure that the drop box collection occurs subsequent to your placement of the sample within the drop box. The sample must not remain uncollected overnight.
*Test marketed within the MOL research program. The purchaser consents to give feedback data to MOL. This data is pre-approved for anonymous use in this research data program.
What’s Included in the HE4 Blood Test Kit Package?
Self-collection finger prick tube kit
- BCD Microtainer, industry standard*
- A Clear safety bag for sample return.
- Absorbent pad Material
- One Return bag labelled UN3373.
- An Option to add a return label at checkout
- Colour Instructions included
- Online sample registration before return
- Insured Free replacement kit if lost or damaged
- Generic Plain white packaging for privacy and discretion from neighbors
- A Cost-effective standard kit with an upgrade option for £50
- Smart Patient request comments box, read by laboratory staff to improve quality and communication
*During shortage,s we may substitutea CE-approved alternative.e.
How long does it take for get the Blood HE4 Results?
The typical turnaround time is 1-3 days. Do note that while we aim to give you results as quickly as possible, the exact result processing time may vary. We are committed to following strict guidelines to ensure quick and accurate results, including staff training, audits, logging, and quality control. The close proximity of our laboratory to our clinic allows us to instantly analyze HE4 samples.
We suggest taking your sample from Monday to Thursday to avoid delivery delays from our laboratory.
HE4 Scientific Data Ascot:
Method: Fluorescence quantitative immunoassay
Detection limits:
Less than or equal to 50.00 pmol/L.
Accuracy and Precision:
The relative standard deviation from the target value is ≤ 15%. The within assay CV is ≤ 15%. The between assay CV is ≤ 15%.
Measuring Range:
50.00~1000.00 pmol/L
Validation-Active Information:
- EQA:
- Inter-laboratory validations
- Periodic according to the validation schedule.
- Event-triggered.
In range results:
The reference range for healthy females and males is less than 140 pmol/L.
Out-of-range results:
Any result greater than the reference range would be considered abnormal.
Page Quality Review:
Review Date : 28/01/2026
Reviewed By :
Over the past couple of years, significant advancements have been made in HE4 and more.
Monitoring techniques have improved, but challenges still exist. The affordable cancer CA125 blood kit has been vital for detecting and tracking diseases. While its accuracy and effectiveness have increased, efforts continue to make it safer and more useful. HPV tests also play a key role in detecting and controlling the virus. This article reviews the latest PCR kit developments in London and discusses the challenges ahead. We’ll also explore monitoring products and the issues that remain, highlighting their importance in fighting ovarian viral damage.
Advancements
1. Swift and Accessible
- Papilloma Virus monitoring.
- These Home kits deliver quick results, usually within minutes, making them very useful for immediate detection.
- Rapid antigen kits are portable and affordable. So they can be used in many settings, including remote areas and community programs.
2. Molecular: Enhanced Accuracy and Precision
- Molecular screening methods such as PCR remain the gold standard for detecting coronavirus.
- PCR kits offer high sensitivity and specificity. This helps ensure accurate virus detection.
3. Serological HE4 Monitoring: Unveiling Past Infections
- And the new Serological tests detect antibodies produced by the immune system in response to HPV.
- This new method helps identify people who were infected previously, even if they showed no symptoms.
- Most Serological exams contribute to understanding the prevalence and spread of the virus within all populations.
Challenges in Screening
1. Supply Chain Issues: Shortages and Distribution Challenges
The HPV PCR tests in London rely on a complex supply chain that includes kits, reagents, swabs, and protective gear. Demand for CA125 supplies often exceeds supply, leading to shortages and delays. Ensuring fair distribution is also difficult, especially in areas with limited resources.
2. Monitoring Accuracy: And Staying Ahead of the Curve
And the New coronavirus variants make it harder to maintain accurate test results. Virus mutations can affect diagnostic tests, sometimes causing false negatives or false positives. And Continuous monitoring and updating of testing methods are essential to keep up with these new changes.
3. Accessibility and Vaccine Coverage
But despite progress, all access to testing remains unequal worldwide. Many underserved communities and developing countries lack the resources for widespread monitoring. Since HPV vaccination success depends on effective monitoring to track and control the virus, making testing accessible is very important.
Advancements:
- Increased Sensitivity and Specificity:
Advances in antigen 125 monitoring have greatly improved its sensitivity and specificity for detecting ovarian problems. New methods and materials have made the test more precise, reducing the chance of false negatives or positives. These improvements help detect issues earlier and more accurately, allowing timely treatment and better patient outcomes.
- Biomarker Combinations:
Researchers recognise that cancer antigen 125 alone has limitations as a biomarker, so they combine it with other biomarkers, such as HE4 and ROMA (Risk of Ovarian Malignancy Algorithm), to improve its usefulness. This combined approach increases specificity and shows promise for detecting new diseases and distinguishing benign from malignant conditions.
- Role in Monitoring Treatment Response:
The cancer antigen 125 test is useful for initial diagnosis and for tracking treatment response and disease progression. Advances have improved how well it indicates treatment success and disease recurrence. Regular monitoring provides doctors with important information to guide treatment decisions and personalize patient care.
Challenges:
- Lack of Specificity:
Although CA125 is a standard cancer biomarker, it is not specific enough for a definitive diagnosis. Elevated levels can also appear in benign conditions like endometriosis and PID. This makes it difficult to distinguish benign from malignant cases based only on CA125 results.
Limited Applicability in the Early Stage:
Although the sensitivity of antigen 125 monitoring has improved, it still has limits in detecting tumours early. Ovarian disease often presents with vague or no symptoms at first, making early detection difficult. Researchers are developing new biomarkers and screening methods to identify the root disease earlier.
Dynamic Nature:
However, Cancer antigen 125 levels can change due to factors such as the menstrual cycle, pregnancy, and other cancers. These changes can cause varied results, making clinical decisions uncertain. More research is needed to better understand and manage these fluctuations to ensure accurate CA125 test results. The CA125 blood test has also seen
significant improvements in the technology. Such as increasing its sensitivity and specificity and expanding its role in detecting and monitoring tumours. Technologies like rapid antigen testing, molecular monitoring, and serological sampling have changed how we detect and track the disease. However, challenges with the supply chain, variant detection, and test availability remain. But this requires collaboration among scientists and healthcare workers. And the doctors. By addressing these challenges, we can improve monitoring strategies and better figh
t the spread of HPV worldwide. For the ovarian tumour threat, further research is essential to overcome challenges with cancer antigen kits. Improving this tool will help us detect disease earlier, improve patient outcomes, and ultimately save more lives.
Shipping and Return Policies
Appointment:
Missed appointments or cancellations less than 24 hours prior are not entitled to refunds. Rescheduling is possible but not guaranteed. Please contact the customer service prior to the appointment time to discuss cost and availability options.
Shipping & Return:
We have a 14-day return policy, which means you have 14 days after receiving your item to request a return.
To Qualify for any return, the product must be in the same condition as when you received it. Not used, not opened, unworn, in its original packaging. You will also need to send it to us with the receipt or proof of purchase.
Please return to: Medicines by MailBox, 89 Falcon Rd, London. SW11 2PF
You can read our full return policy here:
https://medicinesbymailbox.co.uk/return-policy/
We offer next day delivery; however courier delivery times are out of our control. We are unable to offer refunds for any late deliveries. But you will receive courier tracking information once your order has been dispatched. And orders placed by 1pm are dispatched on the same day.
Shipping & Return:
We offer next-day delivery for the HE4 Ovarian Cancer sensitivity kit. However, please also note that the courier delivery times are out of our control and late deliveries are NOT REFUNDABLE.
Orders which are placed by 1 p.m are dispatched on the same business day.
We provide a 14-day return policy, meaning that you will have 14 days (2 weeks) after receiving your item to request a return.
To qualify for a return, please note that the product must be unused, unworn, and in original condition similar to when you had received it.
Return Address: Medicines Online, 89 Falcon Rd, London. SW11 2PF.
https://ascotpharmacy.co.uk/return-policy/
Principle IVD Regulatory Certification
-
MHRA Registration Number: 9489 – Sample Tube & Swab
-
MHRA Registration Number: 9489 – BD Microtainer Tube
HE4 (Ovarian cancer sensitivity)
Rita P. –
Received my results promptly and accurately. Very pleased with the efficiency of this health testing company!